Allergy Therapeutics PLC
LSE:AGY

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
LSE:AGY
Watchlist
Price: 11.25 GBX Market Closed
Market Cap: 690.9m GBX

Wall Street
Price Targets

AGY Price Targets Summary
Allergy Therapeutics PLC

Wall Street analysts forecast AGY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AGY is 13.26 GBX with a low forecast of 13.13 GBX and a high forecast of 13.65 GBX.

Lowest
Price Target
13.13 GBX
17% Upside
Average
Price Target
13.26 GBX
18% Upside
Highest
Price Target
13.65 GBX
21% Upside
Allergy Therapeutics PLC Competitors:
Price Targets
195940
HK Inno.N Corp
30% Upside
LINCOLN
Lincoln Pharmaceuticals Ltd
114% Upside
MRK
Merck & Co Inc
3% Upside
002294
Shenzhen Salubris Pharmaceuticals Co Ltd
19% Downside
ARVN
Arvinas Inc
9% Upside
086450
Dongkook Pharmaceutical Co Ltd
46% Upside
2096
Simcere Pharmaceutical Group Ltd
36% Upside

Revenue
Forecast

Revenue Estimate
Allergy Therapeutics PLC

For the last 13 years the compound annual growth rate for Allergy Therapeutics PLC's revenue is 2%. The projected CAGR for the next 1 year is 44%.

2%
Past Growth
44%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Allergy Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Allergy Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-72%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AGY's stock price target?
Price Target
13.26 GBX

According to Wall Street analysts, the average 1-year price target for AGY is 13.26 GBX with a low forecast of 13.13 GBX and a high forecast of 13.65 GBX.

What is Allergy Therapeutics PLC's Revenue forecast?
Projected CAGR
44%

For the last 13 years the compound annual growth rate for Allergy Therapeutics PLC's revenue is 2%. The projected CAGR for the next 1 year is 44%.

Back to Top